PCSK9 inhibitors are a class of drugs used to lower cholesterol levels, specifically low-density lipoprotein cholesterol (LDL-C). They work by blocking the activity of the proprotein convertase subtilisin/kexin type 9 (PCSK9) enzyme, which leads to increased removal of LDL-C from the bloodstream.
